blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1572943

EP1572943 - CIRCULAR NUCLEIC ACID VECTORS, AND METHODS FOR MAKING AND USING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.02.2016
Database last updated on 14.09.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, CY, HU, SE, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
The Board of Trustees of The Leland S. Stanford Junior University
900 Welch Road, Suite 350
Palo Alto, CA 94304 / US
[2005/37]
Inventor(s)01 / KAY, Mark, A.
565 Casita Way
Los Altos, CA 94305 / US
02 / CHEN, Zhi-Ying
2211 Latham Street 116
Mountain View, CA 94041 / US
 [2005/37]
Representative(s)Campbell, Joanne Marie
Stevens, Hewlett & Perkins
1 St. Augustine's Place
Bristol BS1 4UD / GB
[N/P]
Former [2015/17]Heaton, Joanne Marie
Stevens, Hewlett & Perkins
1 St. Augustine's Place
Bristol BS1 4UD / GB
Former [2007/17]Heaton, Joanne Marie
Stevens, Hewlett & Perkins 1 St. Augustine's Place
Bristol BS1 4UD / GB
Former [2005/37]Wilkinson, Stephen John
Stevens, Hewlett & Perkins 1 St. Augustine's Place
Bristol BS1 4UD / GB
Application number, filing date03749280.828.08.2003
[2005/37]
WO2003US27294
Priority number, dateUS20020407344P29.08.2002         Original published format: US 407344 P
US20030463672P16.04.2003         Original published format: US 463672 P
[2005/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004020605
Date:11.03.2004
Language:EN
[2004/11]
Type: A2 Application without search report 
No.:EP1572943
Date:14.09.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 11.03.2004 takes the place of the publication of the European patent application.
[2005/37]
Type: B1 Patent specification 
No.:EP1572943
Date:22.04.2015
Language:EN
[2015/17]
Search report(s)International search report - published on:US19.10.2006
(Supplementary) European search report - dispatched on:EP21.05.2007
ClassificationIPC:C12N15/02, C12N15/00
[2007/03]
CPC:
C12N15/64 (EP,US); A61K48/005 (EP,US); A61P1/16 (EP);
A61P43/00 (EP); A61P9/00 (EP); C12N15/70 (EP,US);
C12N15/85 (EP,US); C12N2800/108 (EP,US); C12N2800/30 (EP,US);
C12N2800/80 (EP,US); C12N2830/002 (EP,US); C12N2830/55 (EP,US) (-)
Former IPC [2005/37]C12N1/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2015/17]
Former [2005/37]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZIRKULÄRE NUKLEINSÄUREVEKTOREN SOWIE VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON[2005/37]
English:CIRCULAR NUCLEIC ACID VECTORS, AND METHODS FOR MAKING AND USING THE SAME[2005/37]
French:VECTEURS CIRCULAIRES D'ACIDES NUCLEIQUES ET PROCEDES DE PREPARATION ET D'UTILISATION DE CEUX-CI[2005/37]
Entry into regional phase02.02.2005National basic fee paid 
02.02.2005Search fee paid 
02.02.2005Designation fee(s) paid 
02.02.2005Examination fee paid 
Examination procedure26.03.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
02.02.2005Examination requested  [2005/37]
18.01.2007Amendment by applicant (claims and/or description)
29.08.2007Despatch of a communication from the examining division (Time limit: M06)
28.02.2008Reply to a communication from the examining division
07.04.2008Despatch of a communication from the examining division (Time limit: M06)
01.09.2008Reply to a communication from the examining division
20.11.2008Despatch of a communication from the examining division (Time limit: M06)
15.05.2009Reply to a communication from the examining division
21.07.2009Invitation to provide information on prior art
18.11.2009Reply to the invitation to provide information on prior art
08.07.2010Date of oral proceedings
31.08.2010Despatch of communication that the application is refused, reason: substantive examination {1}
31.08.2010Minutes of oral proceedings despatched
14.07.2014Despatch of a communication from the examining division (Time limit: M04)
17.07.2014Reply to a communication from the examining division
18.12.2014Communication of intention to grant the patent
12.03.2015Fee for grant paid
12.03.2015Fee for publishing/printing paid
12.03.2015Receipt of the translation of the claim(s)
Appeal following examination08.11.2010Appeal received No.  T0342/11
07.01.2011Statement of grounds filed
23.05.2014Result of appeal procedure: remittal for grant
23.05.2014Date of oral proceedings
02.06.2014Minutes of oral proceedings despatched
Divisional application(s)EP14168527.1  / EP2801614
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.08.2007
Opposition(s)25.01.2016No opposition filed within time limit [2016/13]
Fees paidRenewal fee
12.08.2005Renewal fee patent year 03
14.08.2006Renewal fee patent year 04
28.08.2007Renewal fee patent year 05
28.08.2008Renewal fee patent year 06
12.08.2009Renewal fee patent year 07
17.08.2010Renewal fee patent year 08
11.08.2011Renewal fee patent year 09
10.08.2012Renewal fee patent year 10
19.08.2013Renewal fee patent year 11
13.08.2014Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.08.2003
AT22.04.2015
BE22.04.2015
BG22.04.2015
CY22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
IT22.04.2015
MC22.04.2015
NL22.04.2015
RO22.04.2015
SE22.04.2015
SI22.04.2015
SK22.04.2015
TR22.04.2015
GR23.07.2015
PT24.08.2015
IE28.08.2015
LU28.08.2015
CH31.08.2015
LI31.08.2015
[2017/39]
Former [2016/37]AT22.04.2015
BE22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
IT22.04.2015
MC22.04.2015
NL22.04.2015
RO22.04.2015
SI22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
IE28.08.2015
LU28.08.2015
CH31.08.2015
LI31.08.2015
Former [2016/33]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
IT22.04.2015
MC22.04.2015
NL22.04.2015
RO22.04.2015
SI22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
IE28.08.2015
LU28.08.2015
CH31.08.2015
LI31.08.2015
Former [2016/24]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
IT22.04.2015
MC22.04.2015
NL22.04.2015
RO22.04.2015
SI22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
LU28.08.2015
CH31.08.2015
LI31.08.2015
Former [2016/22]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
IT22.04.2015
MC22.04.2015
NL22.04.2015
RO22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
LU28.08.2015
CH31.08.2015
LI31.08.2015
Former [2016/21]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
IT22.04.2015
MC22.04.2015
NL22.04.2015
RO22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
LU28.08.2015
Former [2016/18]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
MC22.04.2015
NL22.04.2015
RO22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
LU28.08.2015
Former [2016/17]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
NL22.04.2015
RO22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
LU28.08.2015
Former [2016/10]AT22.04.2015
CZ22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
NL22.04.2015
RO22.04.2015
SK22.04.2015
GR23.07.2015
PT24.08.2015
Former [2016/09]AT22.04.2015
DK22.04.2015
EE22.04.2015
ES22.04.2015
FI22.04.2015
NL22.04.2015
GR23.07.2015
PT24.08.2015
Former [2016/07]AT22.04.2015
DK22.04.2015
ES22.04.2015
FI22.04.2015
NL22.04.2015
GR23.07.2015
PT24.08.2015
Former [2015/51]AT22.04.2015
ES22.04.2015
FI22.04.2015
NL22.04.2015
GR23.07.2015
PT24.08.2015
Former [2015/49]ES22.04.2015
FI22.04.2015
NL22.04.2015
GR23.07.2015
PT24.08.2015
Former [2015/42]NL22.04.2015
Documents cited:Search[X]WO9409127  (US HEALTH [US]) [X] 1-3,5-12,16-27,30-34 * the whole document *;
 [X]EP1035208  (SUMITOMO PHARMA [JP]) [X] 1-3,5-16 * the whole document *;
 [PX]WO02083889  (IMP COLLEGE INNOVATIONS LTD [GB], et al) [PX] 1-13,16-21,24-36 * the whole document *;
 [X]  - DARQUET A-M ET AL, "MINICIRCLE: AN IMPROVED DNA MOLECULE FOR IN VITRO AND IN VIVO GENE TRANSFER", GENE THERAPY, MACMILLAN PRESS LTD., BASINGSTOKE, GB, (199902), vol. 6, no. 2, ISSN 0969-7128, pages 209 - 218, XP001000924 [X] 1-3,5-13,16-21,24-27,30-34,14,15,22,23 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.gt.3300816
 [X]  - BIGGER B W ET AL, "AN ARAC-CONTROLLED BACTERIAL CRE EXPRESSION SYSTEM TO PRODUCE DNA MICROCIRCLE VECTORS FOR NUCLEAR AND MITOCHONDRIAL GENE THERAPY", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (20010622), vol. 276, no. 25, ISSN 0021-9258, pages 23018 - 23027, XP001121110 [X] 1-3,5-13,16 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M010873200
 [T]  - CHEN ZHI-YING ET AL, "Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo", HUMAN GENE THERAPY, (200501), vol. 16, no. 1, ISSN 1043-0342, pages 126 - 131, XP002431639 [T] * the whole document *

DOI:   http://dx.doi.org/10.1089/hum.2005.16.126
 [T]  - CHEN Z Y ET AL, "Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo", GENE THERAPY, (200405), vol. 11, no. 10, ISSN 0969-7128, pages 856 - 864, XP002431640 [T] * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.gt.3302231
International search[X]  - DARQUET A.M. ET AL., "Minicircle an improved DNA molecule for in vitro and in vivo gene transfer", GENE THERAPY, (199902), vol. 6, no. 2, pages 209 - 218, XP001000924

DOI:   http://dx.doi.org/10.1038/sj.gt.3300816
 [X]  - BIGGER B.W. ET AL., "An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (20010622), vol. 276, no. 25, pages 23018 - 23027, XP001121110

DOI:   http://dx.doi.org/10.1074/jbc.M010873200
 [A]  - CHEN Z.Y. ET AL., "Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo", MOLECULAR THERAPY, (200309), vol. 8, no. 3, pages 495 - 500, XP002292220

DOI:   http://dx.doi.org/10.1016/S1525-0016(03)00168-0
Examination   - THORPE H.M. ET AL, "In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (1998), vol. 95, ISSN 0027-8424, pages 5505 - 5510, XP002157128

DOI:   http://dx.doi.org/10.1073/pnas.95.10.5505
    - GROTH A.C. ET AL, "A phage integrase directs efficient site-specific integration in human cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,, WASHINGTON, DC.; US, (20000523), vol. 97, no. 11, pages 5995 - 6000, XP002221880

DOI:   http://dx.doi.org/10.1073/pnas.090527097
    - THYAGARAJAN B. ET AL, "Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, (20010601), vol. 21, no. 12, pages 3926 - 3934, XP002231556

DOI:   http://dx.doi.org/10.1128/MCB.21.12.3926-3934.2001
by applicantUS5922687
 US5985847
 WO02083889
 WO2011000092
    - THORPE ET AL., PNAS, (1998), vol. 95, pages 5505 - 551 0
    - GROTH ET AL., PNAS 97, (1997), vol. 11, pages 5995 - 6000
    - DARQUET ET AL., Gene Therapy, MACMILLAN PRESS, (199902), vol. 6
    - WOLFF ET AL., "Direct Gene Transfer Into Mouse Muscle In Vivo", SCIENCE, (199003), vol. 247, doi:doi:10.1126/science.1690918, pages 1465 - 1468, XP000293057

DOI:   http://dx.doi.org/10.1126/science.1690918
    - HICKMAN ET AL., "Gene Expression Following Direct Injection of DNA Into Liver", HUM. GEN. THER., (199412), vol. 5, pages 1477 - 1483
    - ACSADI ET AL., "Direct Gene Transfer and Expression Into Rat Heart In Vivo", NEW BIOL., (199101), vol. 3, pages 71 - 81
    - DIJKEMA ET AL., EMBO J., (1985), vol. 4, page 761
    - GORMAN ET AL., PROC. NAT'1 ACAD. SCI USA, (1982), vol. 79, page 6777
    - BOSHART ET AL., CELL, (1985), vol. 41, page 521
    - LEVY-HOLTZMAN ,R.; SCHECHTER, BIOCHIM. BIOPHYS. ACTA, (1995), vol. 1263, pages 96 - 98
    - PRESNAIL, J.K.; M.A. HOY, EXP. APPL. ACAROL., (1994), vol. 18, pages 301 - 308
    - GODDARD ET AL., GENE THERAPY, (1997), vol. 4, pages 1231 - 1236
    - GORMAN ET AL., GENE THERAPY, (1997), vol. 4, pages 983 - 992
    - CHADWICK ET AL., GENE THERAPY, (1997), vol. 4, pages 937 - 942
    - GOKHALE ET AL., GENE THERAPY, (1997), vol. 4, pages 1289 - 1299
    - GAO; HUANG, GENE THERAPY, (1995), vol. 2, pages 710 - 722
    - MONAHAN ET AL., GENE THERAPY, (1997), vol. 4, pages 40 - 49
    - ONODERA ET AL., BLOOD, (1998), vol. 91, pages 30 - 36
    - FINGL ET AL., The Pharmacological Basis of Therapeutics, (1975), page L
    - LIEBER ET AL., "Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes", J VIROL., (199612), vol. 70, no. 12, pages 8782 - 91, XP002200431
    - LIEBER ET AL., "Related Articles Adenovirus-mediated expression of ribozymes in mice", J VIROL., (199605), vol. 70, no. 5, pages 3153 - 8
    - TANG ET AL., "Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension", AM J PHYSIOL., (199912), vol. 277, no. 6, pages H2392 - 9
    - HORSTER ET AL., "Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy", GENE THER., (199907), vol. 6, no. 7, pages 1231 - 8
    - PHILLIPS ET AL., "Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense", HYPERTENSION, (199701), vol. 29, no. 1, pages 374 - 80
    - GROTH, A.C.; OLIVARES, E.C.; THYAGARAJAN, B.; CALOS, M.P, "A phage integrase directs efficient site-specific integration in human cells", PROC NATL ACAD SCI U S A, (2000), vol. 97, doi:doi:10.1073/pnas.090527097, pages 5995 - 6000, XP002221880

DOI:   http://dx.doi.org/10.1073/pnas.090527097
    - CHEN, Z.Y. ET AL., "Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver", MOL THER, (2001), vol. 3, doi:doi:10.1006/mthe.2001.0278, pages 403 - 410, XP002292302

DOI:   http://dx.doi.org/10.1006/mthe.2001.0278
    - MIAO, C.H. ET AL., "Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro", MOL THER, (2000), vol. 1, pages 522 - 532, XP002550493
    - MIAO, C.H.; THOMPSON, A.R.; LOEB, K.; YE, X, "Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo", MOL THER, (2001), vol. 3, doi:doi:10.1006/mthe.2001.0333, pages 947 - 957, XP055143164

DOI:   http://dx.doi.org/10.1006/mthe.2001.0333
    - ZHANG, G.; BUDKER, V.; WOLFF, J.A, "High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA", HUM GENE THER, (1999), vol. 10, doi:doi:10.1089/10430349950017734, pages 1735 - 1737, XP002201559

DOI:   http://dx.doi.org/10.1089/10430349950017734
    - LIU, F.; SONG, Y.; LIU, D, "Hydrodynamics-based transformation in animals by systemic administration of plasmid DNA", GENE THER, (1999), vol. 6, pages 1258 - 1266
    - YANT, S.R. ET AL., "Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system", NAT GENET, (2000), vol. 25, doi:doi:10.1038/75568, pages 35 - 41, XP002946960

DOI:   http://dx.doi.org/10.1038/75568
    - GAL, D. ET AL., "Direct myocardial transformation in two animal models. Evaluation of parameters affecting gene expression and percutaneous gene delivery", LAB INVEST, (1993), vol. 68, pages 18 - 25
    - WOLFF, J.A.; LUDTKE, J.J.; ACSADI, G.; WILLIAMS, P.; JANI, A., "Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle", HUM MOL GENET, (1992), vol. 1, pages 363 - 369
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.